JP2000505072A5 - - Google Patents

Download PDF

Info

Publication number
JP2000505072A5
JP2000505072A5 JP1997524869A JP52486997A JP2000505072A5 JP 2000505072 A5 JP2000505072 A5 JP 2000505072A5 JP 1997524869 A JP1997524869 A JP 1997524869A JP 52486997 A JP52486997 A JP 52486997A JP 2000505072 A5 JP2000505072 A5 JP 2000505072A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997524869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000505072A (ja
JP4349657B2 (ja
Filing date
Publication date
Priority claimed from DE19600934A external-priority patent/DE19600934A1/de
Application filed filed Critical
Publication of JP2000505072A publication Critical patent/JP2000505072A/ja
Publication of JP2000505072A5 publication Critical patent/JP2000505072A5/ja
Application granted granted Critical
Publication of JP4349657B2 publication Critical patent/JP4349657B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP52486997A 1996-01-12 1997-01-10 置換アザ―及びジアザシクロヘプタン―及び―シクロオクタン化合物及びその使用 Expired - Lifetime JP4349657B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19600934A DE19600934A1 (de) 1996-01-12 1996-01-12 Substituierte Aza- und Diazacycloheptan- und Cyclooctanverbindungen und deren Verwendung
DE19600934.0 1996-01-12
PCT/EP1997/000106 WO1997025324A1 (de) 1996-01-12 1997-01-10 Substituierte aza- und diazacycloheptan- und -cyclooctanverbindungen und deren verwendung

Publications (3)

Publication Number Publication Date
JP2000505072A JP2000505072A (ja) 2000-04-25
JP2000505072A5 true JP2000505072A5 (cg-RX-API-DMAC10.html) 2004-11-11
JP4349657B2 JP4349657B2 (ja) 2009-10-21

Family

ID=7782613

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52486997A Expired - Lifetime JP4349657B2 (ja) 1996-01-12 1997-01-10 置換アザ―及びジアザシクロヘプタン―及び―シクロオクタン化合物及びその使用

Country Status (26)

Country Link
US (2) US6214822B1 (cg-RX-API-DMAC10.html)
EP (1) EP0877744B1 (cg-RX-API-DMAC10.html)
JP (1) JP4349657B2 (cg-RX-API-DMAC10.html)
KR (1) KR100441073B1 (cg-RX-API-DMAC10.html)
CN (2) CN1075070C (cg-RX-API-DMAC10.html)
AR (1) AR005868A1 (cg-RX-API-DMAC10.html)
AT (1) ATE273301T1 (cg-RX-API-DMAC10.html)
AU (1) AU717726B2 (cg-RX-API-DMAC10.html)
BG (1) BG64098B1 (cg-RX-API-DMAC10.html)
CA (1) CA2241787C (cg-RX-API-DMAC10.html)
CO (1) CO4790173A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ297981B6 (cg-RX-API-DMAC10.html)
DE (2) DE19600934A1 (cg-RX-API-DMAC10.html)
ES (1) ES2225947T3 (cg-RX-API-DMAC10.html)
HR (1) HRP970021A2 (cg-RX-API-DMAC10.html)
HU (1) HU228457B1 (cg-RX-API-DMAC10.html)
IL (1) IL125076A (cg-RX-API-DMAC10.html)
MX (1) MX9805499A (cg-RX-API-DMAC10.html)
NO (1) NO316753B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ326332A (cg-RX-API-DMAC10.html)
PL (1) PL327692A1 (cg-RX-API-DMAC10.html)
SK (1) SK284987B6 (cg-RX-API-DMAC10.html)
TR (1) TR199801302T2 (cg-RX-API-DMAC10.html)
TW (1) TW475929B (cg-RX-API-DMAC10.html)
WO (1) WO1997025324A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA97209B (cg-RX-API-DMAC10.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19728996A1 (de) * 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
ES2255311T3 (es) 1998-10-08 2006-06-16 Smithkline Beecham Plc Derivados de tetrahidrobenzazepina utiles como moduladores de los receptores d3 de dopamina (agentes anti-psicoticos).
AR022229A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
DE19922443A1 (de) * 1999-05-07 2000-11-09 Basf Ag Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
US7037916B2 (en) 1999-07-15 2006-05-02 Pharmacopeia Drug Discovery, Inc. Pyrimidine derivatives as IL-8 receptor antagonists
DE50114170D1 (de) * 2000-03-27 2008-09-11 Abbott Gmbh & Co Kg Dopamin-d3-rezeptor-liganden zur behandlung von sucht
AU2002250107B8 (en) 2001-02-16 2008-06-12 Aventis Pharmaceuticals Inc. Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
DE10109866A1 (de) * 2001-03-01 2002-09-05 Abbott Gmbh & Co Kg Triazolverbindungen und deren Verwendung zur Prophylaxe und Therapie neurodegenerativer Erkrankungen, Hirntrauma und zerebraler Ischämie
DE10131543A1 (de) * 2001-06-29 2003-01-16 Abbott Lab Pyrimidinoxyalkylpiperazine und ihre therapeutische Verwendung
TWI283670B (en) * 2001-11-28 2007-07-11 Sod Conseils Rech Applic 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as a medicament
CN1642422A (zh) * 2002-03-15 2005-07-20 西巴特殊化学品控股有限公司 4-氨基嘧啶及其在表面抗菌处理中的应用
DE10304870A1 (de) * 2003-02-06 2004-08-19 Abbott Gmbh & Co. Kg Triazolverbindungen und ihre therapeutische Verwendung
TW200507841A (en) * 2003-03-27 2005-03-01 Glaxo Group Ltd Antibacterial agents
DE10358004A1 (de) * 2003-12-11 2005-07-14 Abbott Gmbh & Co. Kg Ketolactam-Verbindungen und ihre Verwendung
DE102004027358A1 (de) * 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
FR2877005A1 (fr) * 2004-10-22 2006-04-28 Bioprojet Soc Civ Ile Nouveaux derives d'arylpiperazine
WO2006081289A2 (en) * 2005-01-25 2006-08-03 Glaxo Group Limited Antibacterial agents
JP2007106746A (ja) * 2005-09-13 2007-04-26 Tosoh Corp 新規アリールホモピペラジン類、またはその塩と製造方法
US7935706B2 (en) * 2006-02-23 2011-05-03 Shionogi & Co., Ltd. Nitrogen-containing heterocycle derivatives substituted with cyclic group
EP2004166A2 (en) * 2006-03-31 2008-12-24 La Jolla Pharmaceutical Company Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
EP1882688A1 (en) * 2006-07-25 2008-01-30 EPFL Ecole Polytechnique Fédérale de Lausanne Labelling of fusion proteins with synthetic probes
JP4840440B2 (ja) * 2008-12-24 2011-12-21 ソニー株式会社 画像処理装置およびその方法、並びにプログラム
GB0908394D0 (en) 2009-05-15 2009-06-24 Univ Leuven Kath Novel viral replication inhibitors
GB0913636D0 (en) 2009-08-05 2009-09-16 Univ Leuven Kath Novel viral replication inhibitors
CN102811620B (zh) * 2010-01-25 2015-03-25 Chdi基金会股份有限公司 一些犬尿氨酸-3-单加氧酶抑制剂、药物组合物及其使用方法
WO2012003418A2 (en) * 2010-07-02 2012-01-05 The University Of North Carolina At Chapel Hill Functionally selective ligands of dopamine d2 receptors
EP2640705A2 (en) 2010-11-15 2013-09-25 Katholieke Universiteit Leuven Novel antiviral compounds
WO2013033085A1 (en) 2011-08-30 2013-03-07 Stephen Martin Courtney Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
US9428464B2 (en) 2011-08-30 2016-08-30 Chdi Foundation, Inc. Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
AU2014369926B2 (en) 2013-12-24 2019-07-18 Oncotartis, Inc. Benzamide and nicotinamide compounds and methods of using same
US10258621B2 (en) 2014-07-17 2019-04-16 Chdi Foundation, Inc. Methods and compositions for treating HIV-related disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE628766A (cg-RX-API-DMAC10.html) 1962-12-26
BE792206A (cg-RX-API-DMAC10.html) 1971-12-02 1973-06-01 Byk Gulden Lomberg Chem Fab
US5139998A (en) 1988-08-31 1992-08-18 Superconductor Technologies, Inc. Controlled thallous oxide evaporation for thallium superconductor films and reactor design
SE8803429D0 (sv) 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
US5008267A (en) 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JP2815218B2 (ja) 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
FR2663638B2 (fr) 1990-04-06 1995-02-10 Institut Nal Sante Recherc Medic Polypeptides ayant une activite de recepteur dopaminergique, acides nucleiques codant pour ces polypeptides et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
JP2518965B2 (ja) 1990-09-21 1996-07-31 三井東圧化学株式会社 新規ピリジン誘導体及びそれを有効成分として含有する制癌剤効果増強剤
FR2668771B1 (fr) 1990-11-06 1995-03-17 Inst Nat Sante Rech Med Acides nucleiques codant pour des polypeptides ayant une activite de recepteur dopaminergique humain et utilisation de ces polypeptides pour le criblage de substances actives sur ces polypeptides.
DE4425145A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung von Thiazol- und Thiadiazolverbindungen
DE4425143A1 (de) 1994-07-15 1996-01-18 Basf Ag Substituierte Pyrimidinverbindungen und deren Verwendung
DE4425144A1 (de) 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
DE4425146A1 (de) 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5635503A (en) * 1995-06-07 1997-06-03 Bristol-Myers Squibb Company Dihydropyridine npy antagonists: piperazine derivatives
FR2742149B1 (fr) 1995-12-11 1998-02-13 Inst Nat Sante Rech Med Nouveaux derives de 2-naphtamides et leurs applications therapeutiques

Similar Documents

Publication Publication Date Title
JP2000502280A5 (cg-RX-API-DMAC10.html)
JP2000516114A5 (cg-RX-API-DMAC10.html)
JP2001523983A5 (cg-RX-API-DMAC10.html)
JP2001510326A5 (cg-RX-API-DMAC10.html)
JP2000501771A5 (cg-RX-API-DMAC10.html)
JP2000517304A5 (cg-RX-API-DMAC10.html)
JP2000501599A5 (cg-RX-API-DMAC10.html)
JP2000503005A5 (cg-RX-API-DMAC10.html)
JP2001506646A5 (cg-RX-API-DMAC10.html)
JP2000502472A5 (cg-RX-API-DMAC10.html)
JP2000501825A5 (cg-RX-API-DMAC10.html)
JP2000516984A5 (cg-RX-API-DMAC10.html)
JP2000502485A5 (cg-RX-API-DMAC10.html)
JP2000502425A5 (cg-RX-API-DMAC10.html)
JP2000502568A5 (cg-RX-API-DMAC10.html)
JP2000501774A5 (cg-RX-API-DMAC10.html)
JP2000502570A5 (cg-RX-API-DMAC10.html)
JP2001502073A5 (cg-RX-API-DMAC10.html)
JP2001513118A5 (cg-RX-API-DMAC10.html)
JP2000501876A5 (cg-RX-API-DMAC10.html)
JP2000501744A5 (cg-RX-API-DMAC10.html)
JP2000505072A5 (cg-RX-API-DMAC10.html)
JP2000501229A5 (cg-RX-API-DMAC10.html)
JP2000502316A5 (cg-RX-API-DMAC10.html)
JP2000514419A5 (cg-RX-API-DMAC10.html)